oligometastatic tumor disease
Conditions
Interventions
Group 1: Retrospective analysis of patients who were treated from 01.01.2010 - 28.02.2023 with radiotherapy and followed up in the oligometastatic stage of the disease.
Sponsors
Universitätsklinikum Heidelberg
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients with extracranial oligometastatic disease (up to 5 lesions or affected (lymph node) regions) who received ablative radiotherapy for the treatment of oligometastases at the respective centers in the period up to 02/2023.
Exclusion criteria
Exclusion criteria: Patients who did not receive therapy for oligometastatic disease.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Establishment of a multicenter cohort with radiation therapy data (RTSTRUCT, RTPLAN, radiation planning CTs), longitudinal imaging data and clinical parameters | — |
Secondary
| Measure | Time frame |
|---|---|
| - Assessment of data heterogeneity / comparability / robustness of analyses on multi-center radiation and imaging data - Longitudinal immunological characterization of individual lesions using the radiomics immune score and association with underlying tumor characteristics and prognosis | — |
Countries
Germany
Contacts
Public ContactMaximilian Knoll
Universitätsklinikum Heidelberg
Outcome results
None listed